Intervet/Schering-Plough Animal Health has opened a state-of-the-art production centre for veterinary vaccines against bacterial infections. The new centre is one of the largest veterinary R&D and manufacturing facilities in the world.
Intervet/Schering-Plough Animal Health has opened a new state-of-the-art production centre for veterinary vaccines against bacterial infections. The new centre is one of the largest veterinary R&D and manufacturing facilities in the world and is a cornerstone of the company’s global vaccine R&D and production network.
The company is investing US$22 million in the new building (located at Biosciences Center Boxmeer, The Netherlands), which has increased the floor space of the bacterial vaccine production unit from approximately 1,500 to 5,500 square metres. It will have four hi-tech production lines for bacterial vaccines with a media preparation capacity in fermentors ranging from 200 to 1,500 liters.
The company claims that the availability of state-of-the-art fermentors and clean rooms, in combination with efficient, integrated up-/downstream processing operations and automation makes the new unit a landmark in veterinary bacterial vaccine manufacturing.
The facility was officially opened on April 22 by Chris Buijink, secretary-general of the Dutch Ministry of Economic Affairs, and was celebrated with a dedicated scientific symposium entitled “Research and Technology in Bacterial Vaccine Development: Opportunities for a One Health Approach”.
The facility, which began constuction in December 2007, is fully compliant with current and anticipated regulatory requirements on Good Manufacturing Practices (GMP) for veterinary medicines, with special sectors for bio-contained zones. In addition, the new facility allows production capacity to be expanded in order to meet the increasing demand for veterinary vaccines.
Helmut Finkler, senior director AH Operations Netherlands, said: “The current expansion demonstrates the long-term commitment of the company towards Biosciences Center Boxmeer, with its tradition and expertise of more than 60 years of development, manufacturing and worldwide distribution of veterinary vaccines.”